Type 2 Diabetes Mellitus. From the start – combination therapy
Modern treatment of T2DM requires a shift in paradigm with appropriate intensification of therapy from the very first time of diabetes diagnosis. This is supported by data showing how even a moderate delay in achieving good glycemic control can translate into a later increased risk of developing dia...
Guardado en:
Autores principales: | Francesco Indovina, Pierpaolo Falcetta, Stefano Del Prato |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb619d96f96a42d595dec160bd095f64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2011) -
Adherence to medicamentous therapy of type 2 diabetes mellitus: results of patient questionnaires
por: Elena Viktorovna Surkova, et al.
Publicado: (2009) -
Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
por: I Yu Demidova, et al.
Publicado: (2009) -
Efficacy of complex pathogenic therapy of diabetic distal neuropathy in patients with type 2 diabetes mellitus
por: Inessa I. Dubinina, et al.
Publicado: (2016) -
Possibilities of application a fixed combination of alogliptin and pioglitazone for type 2 diabetes mellitus treatment
por: M. V. Shestakova, et al.
Publicado: (2021)